Biomaterial Database

DNA synthesis in cells activated for the Epstein-Barr virus. 1975

J G Derge, and S L Birkhead, and T Hemmaplardh

UI	MeSH Term	Description	Entries
D002455	Cell Division	The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.	M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460	Cell Line	Established cell cultures that have the potential to propagate indefinitely.	Cell Lines,Line, Cell,Lines, Cell
D004247	DNA	A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).	DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004279	DNA, Viral	Deoxyribonucleic acid that makes up the genetic material of viruses.	Viral DNA
D004854	Herpesvirus 4, Human	The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies.	Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D000956	Antigens, Viral	Substances elaborated by viruses that have antigenic activity.	Viral Antigen,Viral Antigens,Antigen, Viral
D014170	Transformation, Genetic	Change brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome.	Genetic Transformation,Genetic Transformations,Transformations, Genetic

Related Publications

J G Derge, and S L Birkhead, and T Hemmaplardh

DNA synthesis inhibitors suppress expression of Epstein-Barr virus in chemically activated human lymphoblastoid cells.

January 1986, Intervirology,

J G Derge, and S L Birkhead, and T Hemmaplardh

Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.

September 1973, Virology,

J G Derge, and S L Birkhead, and T Hemmaplardh

Sequence of spontaneous Epstein-Barr virus activation and selective DNA synthesis in activated cells in the presence of hydroxyurea.

September 1972, Proceedings of the National Academy of Sciences of the United States of America,

J G Derge, and S L Birkhead, and T Hemmaplardh

[Epstein-Barr virus DNA in human tumor cells].

May 1972, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,

J G Derge, and S L Birkhead, and T Hemmaplardh

Synthesis of chromosomal proteins and Epstein-Barr virus DNA in activated Burkitt somatic cell hybrids.

October 1980, Virology,

J G Derge, and S L Birkhead, and T Hemmaplardh

Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.

January 2005, Journal of medical virology,

J G Derge, and S L Birkhead, and T Hemmaplardh

Mitochondrial DNA synthesis in Raji cells infected by herpes simplex virus or Epstein-Barr virus.

September 1973, Medical microbiology and immunology,

J G Derge, and S L Birkhead, and T Hemmaplardh

Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas.

September 2001, Current opinion in oncology,